Rezok-DSR (Introduction)
Rezok-DSR is composed of two components: Rabeprazole; which is a proton-pump inhibitor in the strength of 20mg along with 30mg of Domperidone; i.e., an anti-emetic. It is a brand of Brenstem Biosciences.
Rabeprazole belongs to a class of antisecretory compounds (substituted
benzimidazole protonpump inhibitors) that do not exhibit anticholinergic or
histamine H 2 -receptor antagonist properties, but suppress gastric acid
secretion by inhibiting the gastric H + /K + ATPase at
the secretory surface of the gastric parietal cell. Because this enzyme is
regarded as the acid (proton) pump within the parietal cell, rabeprazole has
been characterized as a gastric proton pump
inhibitor. Rabeprazole blocks
the final step of gastric acid secretion. In gastric parietal cells,
rabeprazole is protonated, accumulates, and is transformed to an active
sulfenamide.
Domperidone is a derivative of benzimidazole that possesses both
prokinetic and antiemetic properties due to its inhibitory action at dompamine
D 2 receptors.
Comments
Post a Comment